|
| Status |
Public on Oct 28, 2021 |
| Title |
Morc3 silences endogenous retroviruses in mouse embryonic stem cells [RNA-seq CRISPR] |
| Organism |
Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
Background: MORC proteins are involved in epigenetic gene silencing in a wide variety of eukaryotic organisms. Deletion of MORCs result in several developmental abnormalities and their dysregulation has been implicated in developmental disease and multiple cancers. Specifically, mutations of mammalian MORC3 have been associated with immune system defects, Down syndrome and human cancers such as bladder, uterine, stomach, and lung cancers, and diffuse large B cell lymphomas. While previous studies have shown that MORC3 binds to H3K4me3 in vitro and overlaps with H3K4me3 ChIP-seq peaks in mouse embryonic stem cells, the mechanism by which MORC3 regulates gene expression is unknown. Results: In this study, we find that MORC3 functions as an epigenetic silencer of endogenous retroviruses (ERVs) in mouse embryonic stem cells (mESCs). Loss of MORC3 results in upregulation of ERVs, specifically those belonging to the LTR class of retrotransposons. Using ChIP-seq, we measure the genome-wide localization of MORC3 in wild-type cells and find that MORC3 binds to ERVs suggesting its direct role in regulating ERV expression. Previous studies have shown that these ERVs are marked by repressive histone mark H3K9me3 which plays a key role in their silencing. Interestingly, we find that the levels of H3K9me3 do not change substantially upon the loss of MORC3 indicating that MORC3 possibly acts downstream of the TRIM28/SETDB1 complex that deposits H3K9me3 at these loci. Instead, we discover that loss of MORC3 results in increased chromatin accessibility at the ERVs suggesting that MORC3 silences ERVs by compacting DNA in mESCs. Conclusions: Our results reveal MORC3 as a novel regulator of ERV silencing in mouse embryonic stem cells. As early mammalian development is characterized by dynamic changes in ERV expression, the role of MORC3 in silencing ERVs is exciting and could potentially explain the abnormalities observed due to its misregulation during mammalian development.
|
| |
|
| Overall design |
Expression profiling by high throughput sequencing The RNA-seq analysis includes 3 biologicate replicates of the WT mESC and 3 biologicate replicates of the Morc3 mutant for each RNA-seq experiment
|
| |
|
| Contributor(s) |
Desai VP, Chouaref J, Wu H, Jacobsen SE, Daxinger L |
| Citation(s) |
34706774 |
| |
| Submission date |
May 05, 2021 |
| Last update date |
Jan 12, 2023 |
| Contact name |
Lucia Daxinger |
| E-mail(s) |
[email protected]
|
| Organization name |
Leiden Univeristy Medica Center
|
| Street address |
Albinusdreef 2
|
| City |
Leiden |
| ZIP/Postal code |
2333ZA |
| Country |
Netherlands |
| |
|
| Platforms (1) |
| GPL24247 |
Illumina NovaSeq 6000 (Mus musculus) |
|
| Samples (6)
|
|
| This SubSeries is part of SuperSeries: |
| GSE173917 |
Morc3 silences endogenous retroviruses in mouse embryonic stem cells |
|
| Relations |
| BioProject |
PRJNA727551 |
| SRA |
SRP318571 |
Less...
More...